HELSINKI, FINLAND (NOVEMBER 21, 2019) – Arkansas Children’s Hospital is now home to the TRIUX™ neo, the first and only magnetoencephalography system (MEG) in Arkansas. The TRIUX™ neo is MEGIN’s next generation of MEG technology which is used to detect and localize neural events that are generated in the brain with millimeter accuracy and millisecond resolution. When this information is merged with structural MRI imaging, it provides a view to critical areas of the brain such as those areas responsible for the ability to see, talk, or move. Using this kind of information can confirm a diagnosis when other imaging modalities are inconclusive, thereby increasing the accuracy of surgical intervention and minimizing risk of neurological deficit.
Arkansas Children’s’ team of pediatric epilepsy specialists provide advanced care through state-of-the-art technology and innovative approaches for improved outcomes. Their suite of state-of-the-art technology now includes the TRIUX™ neo. “In Arkansas, we have approximately 7,000 kids with pediatric epilepsy,” says Arkansas Children’s Epileptologist Dr. Debopam Samanta. “Around 2,000 of these children are unresponsive to seizure medicine, but on average, we only do around ten epilepsy surgeries a year. Granted, not everyone will be a candidate, but having MEG technology allows us to identify more appropriate treatment options and provide epilepsy surgery when needed.” The TRIUX™ neo will now allow their physicians to help identify these patients who may benefit from epilepsy surgery and to evaluate brain activity and mapping prior to brain tumor surgery.
The nationally recognized Neurology & Neurosurgery Departments at Arkansas Children’s provides expert epilepsy care as well as comprehensive care for a full range of neurological conditions and diseases.
Based in Helsinki, Finland, MEGIN is the global leader for Magnetoencephalography (MEG) technology. The TRUIX™ neo, launched in 2018, is the fourth-generation Magnetoencephalography system. With a dynamic view of the human brain, TRIUX™ neo provides a non-invasive, real time view of patient specific neural activity with millimeter accuracy and millisecond resolution.